VivoSeq
Cardiovascular

Critical Limb Ischemia

2

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Critical Limb Ischemia is an early-stage landscape with 2 programs across 0 companies. 1 program is in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Ensure Surgery Immunonutrition Shake

Boston Medical Center

Phase 2
No programs
Phase 31

Edetate Disodium

Mt. Sinai Medical Center, Miami

Approved
No programs

Analysis

Trial Status

2

clinical trials

Active, not recruiting1 · 50%
Recruiting1 · 50%

Clinical Trials

Trial Activity

Trial to Assess Chelation Therapy in Critical Limb Ischemia
Active, not recruiting·MMt. Sinai Medical Center, Miami·Phase 3·NCT03982693·50 enrolled
Perioperative Nutritional Optimization in Patients With Critical Limb Ischemia
Recruiting·BBoston Medical Center·Phase 1·NCT03529019·30 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)